| Literature DB >> 35878191 |
Ran Wang1, Qinghe Zhang2, Xuan Zhou2, Mi Zhang3, Qingyi Yang3, Qi Su2, Chen Luo1.
Abstract
Afidopyropen, a newly identified chemical, is a derivative of pyripyropene A, which is produced by the filamentous fungus Penicillium coprobium. It is a promising novel pesticide applied against whiteflies in agriculture. In this study, the reversion and selection, cross-resistance patterns, synergistic effects, and fitness costs of afidopyropen resistance were studied in a field-developed resistant population of B. tabaci. Compared to a reference MED-S strain, the field-developed resistant Haidian (HD) population showed 36.5-fold resistance to afidopyropen. Significant reversion of resistance to afidopyropen was found in the HD population when it was kept with no selective pressure of the insecticide. The HD-Afi strain, developed from the HD population with afidopyropen pressure, developed 104.3-fold resistance to afidopyropen and significant cross-resistance to sulfoxaflor. Piperonyl butoxide (PBO) largely inhibited afidopyropen resistance in the HD-Afi strain, which indicates that P450 monooxygenase could be involved in the resistance. Significant fitness costs associated with afidopyropen resistance were observed in HD-Afi. This study indicates that a rotation of afidopyropen with other chemical control agents could be useful for impeding afidopyropen resistance in B. tabaci. In addition, we expanded upon the understanding of resistance to afidopyropen, offering evidence suggesting the importance of devising better strategies for the management of whiteflies.Entities:
Keywords: Bemisia tabaci; afidopyropen; cross-resistance; fitness costs; insecticidal toxin; synergism
Mesh:
Substances:
Year: 2022 PMID: 35878191 PMCID: PMC9320511 DOI: 10.3390/toxins14070453
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 5.075
Selection of resistance to afidopyropen in the field-collected population of HD.
| HD Strain (without Selection) | HD-Afi Strain (Selected with Afidopyropen) | |||||
|---|---|---|---|---|---|---|
| G a | LC50 (95% CL) b (mg L−1) | Slope ± SE | RR c | LC50 (95% CL) b (mg L−1) | Slope ± SE | RR c |
| 1 | 256.320 (208.229–311.908) | 1.315 ± 0.140 | 36.5 | |||
| 2 | 189.807 (137.770–242.631) | 1.135 ± 0.139 | 27.0 | 299.889 (243.016–362.395) | 1.359 ± 0.141 | 42.7 |
| 3 | 140.582 (108.137–181.141) | 1.014 ± 0.133 | 20.0 | 380.671 (303.682–458.726) | 1.545 ± 0.153 | 54.2 |
| 4 | 77.052 (58.461–97.009) | 1.116 ± 0.137 | 11.0 | 476.515 (329.807–624.553) | 1.001 ± 0.135 | 67.8 |
| 5 | 48.763 (33.716–63.451) | 1.273 ± 0.153 | 6.9 | 534.401 (437.275–634.564) | 1.623 ± 0.154 | 76.0 |
| 6 | 37.446 (31.012–44.505) | 1.522 ± 0.144 | 5.3 | 560.945 (434.339–691.779) | 1.65 ± 0.11 | 79.8 |
| 7 | 21.139 (14.683–27.455) | 1.336 ± 0.152 | 3.0 | 740.959 (578.096–922.376) | 1.52 ± 0.11 | 105.4 |
| 8 | 25.320 (20.076–32.049) | 1.123 ± 0.137 | 3.6 | 715.198 (511.872–914.897) | 1.282 ± 0.148 | 101.7 |
| 9 | 22.536 (18.155–27.733) | 1.238 ± 0.137 | 3.2 | 762.536 (537.838–984.091) | 1.202 ± 0.144 | 108.5 |
| 10 | 20.470 (17.080–24.573) | 1.434 ± 0.139 | 2.9 | 733.063 (491.176–970.479) | 1.106 ± 0.143 | 104.3 |
a Generation of adults used in the bioassay. b CL = confidence limits. c RR (resistance ratio) = LC50 (selected strain or reversed strain)/LC50 (MED-S, 7.029 mg L−1).
Cross-resistance patterns of the afidopyropen-selected HD-Afi strain of B. tabaci.
| Insecticide | Strain | LC50 (mg L−1) (95% CL) a | Slope ± SE | RR1 b | RR2 c |
|---|---|---|---|---|---|
| Afidopyropen | MED-S | 7.104 (5.836–8.486) | 1.465 ± 0.144 | ||
| HD (F10) | 23.994 (18.802–30.420) | 1.076 ± 0.134 | 3.4 | ||
| HD-Afi (F10) | 750.818 (603.966–905.157) | 1.439 ± 0.145 | 105.7 | 31.3 | |
| Cyantraniliprole | MED-S | 1.040 (0.870–1.232) | 1.549 ± 0.146 | ||
| HD (F10) | 0.883 (0.724–1.069) | 1.345 ± 0.139 | 0.8 | ||
| HD-Afi (F10) | 1.341 (0.987–1.706) | 1.148 ± 0.142 | 1.3 | 1.5 | |
| Flupyradifurone | MED-S | 19.502 (14.602–25.191) | 0.989 ± 0.135 | ||
| HD (F10) | 25.232 (19.527–31.054) | 1.340 ± 0.145 | 1.3 | ||
| HD-Afi (F10) | 23.825 (19.811–28.979) | 1.405 ± 0.141 | 1.2 | 0.9 | |
| Imidacloprid | MED-S | 14.172 (11.067–17.590) | 1.193 ± 0.139 | ||
| HD (F10) | 13.542 (10.896–17.321) | 1.176 ± 0.137 | 1.0 | ||
| HD-Afi (F10) | 15.078 (11.115–18.976) | 1.328 ± 0.149 | 1.1 | 1.1 | |
| Sulfoxaflor | MED-S | 8.860 (6.569–11.148) | 1.256 ± 0.144 | ||
| HD (F10) | 11.033 (8.097–13.925) | 1.528 ± 0.143 | 1.2 | ||
| HD-Afi (F10) | 208.212 (174.280–243.020) | 1.875 ± 0.163 | 23.5 | 18.9 | |
| Thiamethoxam | MED-S | 11.152 (8.187–14.119) | 1.220 ± 0.145 | ||
| HD (F10) | 12.224 (9.812–15.214) | 1.192 ± 0.137 | 1.1 | ||
| HD-Afi (F10) | 14.291 (9.891–18.734) | 0.998 ± 0.136 | 1.3 | 1.2 |
a CL = confidence limits. b RR1 (resistance ratio) = LC50 (HD-Afi or HD)/LC50 (MED-S). c RR2 (resistance ratio) = LC50 (HD-Afi)/LC50 (HD).
Synergism of DEF, DEM, and PBO to afidopyropen in different strains of B. tabaci.
| Strain | Insecticide/Synergist | LC50 (mg L−1) (95% CL) a | Slope ± SE | RR | SR b |
|---|---|---|---|---|---|
| MED-S | Afidopyropen | 7.736 (6.141–9.365) | 1.478 ± 0.151 | ||
| Afidopyropen + PBO | 7.051 (5.562–9.310) | 1.045 ± 0.133 | 1.1 | ||
| Afidopyropen + DEM | 7.324 (5.802–9.019) | 1.230 ± 0.140 | 1.1 | ||
| Afidopyropen + TPP | 7.127 (5.777–9.060) | 1.210 ± 0.138 | 1.1 | ||
| HD (F10) | Afidopyropen | 22.002 (16.921–28.872) | 0.970 ± 0.132 | 2.8 | |
| Afidopyropen + PBO | 24.731 (18.825–30.712) | 1.275 ± 0.142 | 3.2 | 0.9 | |
| Afidopyropen + DEM | 25.452 (19.301–33.635) | 0.928 ± 0.131 | 3.3 | 0.9 | |
| Afidopyropen + TPP | 27.871 (22.287–35.190) | 1.126 ± 0.134 | 3.6 | 0.8 | |
| HD-Afi (F10) | Afidopyropen | 732.112 (575.255–905.446) | 1.187 ± 0.135 | 94.6 | |
| Afidopyropen + PBO | 129.914 (101.106–167.823) | 1.016 ± 0.133 | 16.8 | 5.6 | |
| Afidopyropen + DEM | 754.248 (580.028–1039.142) | 0.928 ± 0.131 | 97.5 | 1.0 | |
| Afidopyropen + TPP | 695.300 (536.987–868.780) | 1.129 ± 0.134 | 89.9 | 1.1 |
a CL = confidence limits. b SR (synergistic ratio) = LC50 (afidopyropen only)/LC50 (afidopyropen + synergist).
Figure 1Development duration (A) and survival rate (B) of nymphs and pseudopupae in HD and HD-Afi strains of B. tabaci. Values are presented as the means ± SE. Asterisks above the error bars indicate significant differences (p < 0.05), and n.s. indicates not significant (p > 0.05).
Figure 2Fecundity (A), oviposition duration (B), and egg hatching rate (C) of HD and HD-Afi strains. Values are presented as the means ± SE. Asterisks above the error bars indicate significant differences (p < 0.05), and n.s. indicates not significant (p > 0.05).
Fitness component comparisons and relative fitness in field-collected HD strain and laboratory-selected resistant HD-Afi strain of B. tabaci.
| Fitness Component | HD | HD-Afi |
|---|---|---|
| Number of neonates for tests | 300 | 300 |
| Number of pseudopupae | 238 | 190 |
| Number of adults | 199 | 149 |
| Number of female adults | 91 | 70 |
| Mean eggs laid per female | 129.5 | 104.6 |
| Hatchability (%) | 89.9 | 87.2 |
| Predicted neonate number of next generation | 10594 | 6384 |
| Net reproductive rate (R0) | 35.3 | 21.3 |
| Relative fitness a | 1 | 0.60 |
a Relative fitness = R0 (HD-Afi)/R0 (HD).